• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sigflow:一种用于癌症基因组突变特征分析的自动化和全面的管道。

Sigflow: an automated and comprehensive pipeline for cancer genome mutational signature analysis.

机构信息

School of Life Science and Technology, ShanghaiTech University, Shanghai 201203, China.

Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.

出版信息

Bioinformatics. 2021 Jul 12;37(11):1590-1592. doi: 10.1093/bioinformatics/btaa895.

DOI:10.1093/bioinformatics/btaa895
PMID:33270873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8275980/
Abstract

SUMMARY

Mutational signatures are recurring DNA alteration patterns caused by distinct mutational events during the evolution of cancer. In recent years, several bioinformatics tools are available for mutational signature analysis. However, most of them focus on specific type of mutation or have limited scope of application. A pipeline tool for comprehensive mutational signature analysis is still lacking. Here we present Sigflow pipeline, which provides an one-stop solution for de novo signature extraction, reference signature fitting, signature stability analysis, sample clustering based on signature exposure in different types of genome DNA alterations including single base substitution, doublet base substitution, small insertion and deletion and copy number alteration. A Docker image is constructed to solve the complex and time-consuming installation issues, and this enables reproducible research by version control of all dependent tools along with their environments. Sigflow pipeline can be applied to both human and mouse genomes.

AVAILABILITY AND IMPLEMENTATION

Sigflow is an open source software under academic free license v3.0 and it is freely available at https://github.com/ShixiangWang/sigflow or https://hub.docker.com/r/shixiangwang/sigflow.

SUPPLEMENTARY INFORMATION

Supplementary data are available at Bioinformatics online.

摘要

摘要

突变特征是癌症进化过程中由不同突变事件引起的反复出现的 DNA 改变模式。近年来,有几种生物信息学工具可用于突变特征分析。然而,大多数工具都侧重于特定类型的突变,或应用范围有限。仍然缺乏用于全面突变特征分析的流水线工具。本文介绍了 Sigflow 流水线,它为从头提取特征、参考特征拟合、特征稳定性分析以及基于单碱基替换、双碱基替换、小插入和缺失以及拷贝数改变等不同类型基因组 DNA 改变中特征暴露的样本聚类提供了一站式解决方案。构建了一个 Docker 镜像来解决复杂且耗时的安装问题,这通过对所有相关工具及其环境的版本控制,实现了可重复的研究。Sigflow 流水线可应用于人类和小鼠基因组。

可用性和实现

Sigflow 是一个根据学术自由许可证 v3.0 发布的开源软件,可在 https://github.com/ShixiangWang/sigflow 或 https://hub.docker.com/r/shixiangwang/sigflow 上免费获取。

补充信息

补充数据可在 Bioinformatics 在线获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df9/8275980/06b5df89be36/btaa895f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df9/8275980/06b5df89be36/btaa895f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df9/8275980/06b5df89be36/btaa895f1.jpg

相似文献

1
Sigflow: an automated and comprehensive pipeline for cancer genome mutational signature analysis.Sigflow:一种用于癌症基因组突变特征分析的自动化和全面的管道。
Bioinformatics. 2021 Jul 12;37(11):1590-1592. doi: 10.1093/bioinformatics/btaa895.
2
Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.拷贝数签名分析工具及其在前列腺癌中的应用揭示了不同的突变过程和临床结局。
PLoS Genet. 2021 May 4;17(5):e1009557. doi: 10.1371/journal.pgen.1009557. eCollection 2021 May.
3
SomaticSiMu: a mutational signature simulator.SomaticSiMu:一种突变特征模拟器。
Bioinformatics. 2022 Apr 28;38(9):2619-2620. doi: 10.1093/bioinformatics/btac128.
4
MutVis: Automated framework for analysis and visualization of mutational signatures in pathogenic bacterial strains.MutVis:用于分析和可视化病原菌株中突变特征的自动化框架。
Infect Genet Evol. 2021 Jul;91:104805. doi: 10.1016/j.meegid.2021.104805. Epub 2021 Mar 6.
5
MSA: reproducible mutational signature attribution with confidence based on simulations.MSA:基于模拟具有置信度的可重复突变特征归因。
BMC Bioinformatics. 2021 Nov 4;22(1):540. doi: 10.1186/s12859-021-04450-8.
6
Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer.重写本:一个用于研究癌症中克隆进化过程中突变和结构变异特征的 R 包。
Bioinformatics. 2018 Oct 1;34(19):3380-3381. doi: 10.1093/bioinformatics/bty388.
7
UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena data.UCSCXenaShiny:一个用于交互式分析 UCSC Xena 数据的 R/CRAN 包。
Bioinformatics. 2022 Jan 3;38(2):527-529. doi: 10.1093/bioinformatics/btab561.
8
MetaMutationalSigs: comparison of mutational signature refitting results made easy.MetaMutationalSigs:轻松比较突变特征拟合结果。
Bioinformatics. 2022 Apr 12;38(8):2344-2347. doi: 10.1093/bioinformatics/btac091.
9
SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events.SigProfilerMatrixGenerator:用于可视化和探索小型突变事件模式的工具。
BMC Genomics. 2019 Aug 30;20(1):685. doi: 10.1186/s12864-019-6041-2.
10
ORCA: a comprehensive bioinformatics container environment for education and research.ORCA:一个全面的生物信息学容器环境,用于教育和研究。
Bioinformatics. 2019 Nov 1;35(21):4448-4450. doi: 10.1093/bioinformatics/btz278.

引用本文的文献

1
Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome-wide mutation analysis.同步性子宫内膜/宫颈癌与卵巢/输卵管癌:全基因组突变分析
J Pathol Clin Res. 2025 Sep;11(5):e70040. doi: 10.1002/2056-4538.70040.
2
Competing Subclones and Fitness Diversity Shape Tumor Evolution Across Cancer Types.相互竞争的亚克隆和适应性多样性塑造了不同癌症类型的肿瘤进化。
bioRxiv. 2025 Jun 3:2025.05.31.657191. doi: 10.1101/2025.05.31.657191.
3
Integrated proteogenomic characterization of ampullary adenocarcinoma.壶腹腺癌的综合蛋白质基因组特征分析

本文引用的文献

1
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
2
SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events.SigProfilerMatrixGenerator:用于可视化和探索小型突变事件模式的工具。
BMC Genomics. 2019 Aug 30;20(1):685. doi: 10.1186/s12864-019-6041-2.
3
Maftools: efficient and comprehensive analysis of somatic variants in cancer.Maftools:癌症体细胞变异的高效全面分析。
Cell Discov. 2025 Jan 7;11(1):2. doi: 10.1038/s41421-024-00742-4.
4
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.在一线卡培他滨和奥沙利铂(XELOX)联合贝伐单抗方案基础上加用SHR-1701治疗不可切除的转移性结直肠癌。
Signal Transduct Target Ther. 2024 Dec 16;9(1):349. doi: 10.1038/s41392-024-02063-0.
5
Impaired neutrophil-mediated cell death drives Ewing's Sarcoma in the background of Down syndrome.中性粒细胞介导的细胞死亡受损在唐氏综合征背景下驱动尤因肉瘤。
Front Oncol. 2024 Oct 3;14:1429833. doi: 10.3389/fonc.2024.1429833. eCollection 2024.
6
Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets.乳腺导管癌的蛋白质基因组图谱揭示肿瘤进展特征和治疗靶点。
Adv Sci (Weinh). 2024 Dec;11(46):e2401041. doi: 10.1002/advs.202401041. Epub 2024 Oct 17.
7
Genomic alterations in the stepwise progression from normal mucosa to metastasizing oral squamous cell carcinoma.从正常黏膜到转移性口腔鳞状细胞癌逐步进展过程中的基因组改变。
Front Oncol. 2024 Sep 11;14:1450361. doi: 10.3389/fonc.2024.1450361. eCollection 2024.
8
Whole-Exome Sequencing and Experimental Validation Unveil the Roles of TMEM229A Q200del Mutation in Lung Adenocarcinoma.全外显子组测序和实验验证揭示 TMEM229A Q200del 突变在肺腺癌中的作用。
Clin Respir J. 2024 Aug;18(8):e70006. doi: 10.1111/crj.70006.
9
The genomic landscape of lung cancer in never-smokers from the Women's Health Initiative.从不吸烟者的妇女健康倡议中观察到的肺癌基因组图谱。
JCI Insight. 2024 Jul 25;9(17):e174643. doi: 10.1172/jci.insight.174643.
10
Proteogenomic Workflow for Characterization of Microphthalmia Transcription Factor (MiT) Family Translocation Renal Cell Carcinoma.MiT 家族易位性肾细胞癌的蛋白质基因组学工作流程分析
Methods Mol Biol. 2024;2823:109-127. doi: 10.1007/978-1-0716-3922-1_8.
Genome Res. 2018 Nov;28(11):1747-1756. doi: 10.1101/gr.239244.118. Epub 2018 Oct 19.
4
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer.DNA 修复缺陷所致突变特征在癌症治疗中的意义。
Nat Commun. 2018 Aug 17;9(1):3292. doi: 10.1038/s41467-018-05228-y.
5
APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.APOBEC3B 和 APOBEC 突变特征可作为预测非小细胞肺癌免疫治疗反应的潜在标志物。
Oncogene. 2018 Jul;37(29):3924-3936. doi: 10.1038/s41388-018-0245-9. Epub 2018 Apr 26.
6
Detecting presence of mutational signatures in cancer with confidence.准确检测癌症中突变特征的存在。
Bioinformatics. 2018 Jan 15;34(2):330-337. doi: 10.1093/bioinformatics/btx604.
7
Computational approaches for discovery of mutational signatures in cancer.癌症中突变特征发现的计算方法。
Brief Bioinform. 2019 Jan 18;20(1):77-88. doi: 10.1093/bib/bbx082.
8
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.HRDetect是一种基于突变特征的BRCA1和BRCA2缺陷预测指标。
Nat Med. 2017 Apr;23(4):517-525. doi: 10.1038/nm.4292. Epub 2017 Mar 13.
9
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.体细胞 ERCC2 突变与尿路上皮肿瘤中一种独特的基因组特征相关。
Nat Genet. 2016 Jun;48(6):600-606. doi: 10.1038/ng.3557. Epub 2016 Apr 25.
10
DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.DeconstructSigs:剖析单个肿瘤中的突变过程可区分DNA修复缺陷和癌演变模式。
Genome Biol. 2016 Feb 22;17:31. doi: 10.1186/s13059-016-0893-4.